Hatakeda J, Shimazaki H, Kuramochi I, Iwayama T, Kobayashi S, Matsuki H
PCN Rep. 2024; 3(4):e70045.
PMID: 39711578
PMC: 11659727.
DOI: 10.1002/pcn5.70045.
Kanemura H
J Clin Med. 2024; 13(2).
PMID: 38256539
PMC: 10816334.
DOI: 10.3390/jcm13020405.
Roberts N, Villarreal L, Burleson M
Front Psychiatry. 2023; 14:1135590.
PMID: 37255682
PMC: 10225681.
DOI: 10.3389/fpsyt.2023.1135590.
Mao L, Wang K, Zhang Q, Wang J, Zhao Y, Peng W
Front Public Health. 2022; 10:879895.
PMID: 35558541
PMC: 9087196.
DOI: 10.3389/fpubh.2022.879895.
van der Meulen M, Zamanipoor Najafabadi A, Broersen L, Schoones J, Pereira A, van Furth W
J Clin Endocrinol Metab. 2021; 107(5):1225-1238.
PMID: 34871425
PMC: 9016456.
DOI: 10.1210/clinem/dgab874.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach J, Sills G
Lancet. 2021; 397(10282):1375-1386.
PMID: 33838758
PMC: 8047813.
DOI: 10.1016/S0140-6736(21)00246-4.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach J, Sills G
Lancet. 2021; 397(10282):1363-1374.
PMID: 33838757
PMC: 8047799.
DOI: 10.1016/S0140-6736(21)00247-6.
Epilepsy and quality of life: what does really matter?.
Tombini M, Assenza G, Quintiliani L, Ricci L, Lanzone J, Di Lazzaro V
Neurol Sci. 2021; 42(9):3757-3765.
PMID: 33449244
DOI: 10.1007/s10072-020-04990-6.
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
Balabanova S, Taylor C, Sills G, Burnside G, Plumpton C, Smith P
BMJ Open. 2020; 10(8):e040635.
PMID: 32847927
PMC: 7451282.
DOI: 10.1136/bmjopen-2020-040635.
Genetic attribution and perceived impact of epilepsy in multiplex epilepsy families.
Garofalo D, Sorge S, Hesdorffer D, Winawer M, Phelan J, Chung W
Epilepsia. 2019; 60(11):2286-2293.
PMID: 31587270
PMC: 7144879.
DOI: 10.1111/epi.16352.
Conceptualizing pain-related stigma in adolescent chronic pain: a literature review and preliminary focus group findings.
Wakefield E, Zempsky W, Puhl R, Litt M
Pain Rep. 2018; 3(Suppl 1):e679.
PMID: 30324171
PMC: 6172824.
DOI: 10.1097/PR9.0000000000000679.
Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs.
Holmes E, Plumpton C, Baker G, Jacoby A, Ring A, Williamson P
Clin Pharmacol Ther. 2018; 105(3):672-683.
PMID: 30204252
PMC: 6491963.
DOI: 10.1002/cpt.1231.
The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): A randomized controlled trial.
Ridsdale L, Wojewodka G, Robinson E, Noble A, Morgan M, Taylor S
Epilepsia. 2018; 59(5):1048-1061.
PMID: 29658989
PMC: 5969309.
DOI: 10.1111/epi.14073.
Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model.
Borghs S, Tomaszewski E, Halling K, de la Loge C
Patient. 2016; 9(5):419-31.
PMID: 27002318
DOI: 10.1007/s40271-016-0165-0.
Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial.
Magill N, Ridsdale L, Goldstein L, McCrone P, Morgan M, Noble A
Trials. 2015; 16:269.
PMID: 26068449
PMC: 4488108.
DOI: 10.1186/s13063-015-0788-9.
The life changes in epilepsy scale: development and establishment of content and face validity.
Miller W, Bakas T, Weaver M, Buelow J, Sabau D
Clin Nurse Spec. 2015; 29(2):95-9.
PMID: 25654709
PMC: 4319549.
DOI: 10.1097/NUR.0000000000000109.
Lennox-Gastaut syndrome: impact on the caregivers and families of patients.
Gibson P
J Multidiscip Healthc. 2014; 7:441-8.
PMID: 25336963
PMC: 4199842.
DOI: 10.2147/JMDH.S69300.
Quality of life in people with epilepsy in Sudan: An example of underserved communities in developing countries.
Sokrab M, Sokrab A, Elzubeir M
Qatar Med J. 2014; 2012(2):59-63.
PMID: 25003042
PMC: 3991048.
DOI: 10.5339/qmj.2012.2.14.
Patient-centered outcomes in older adults with epilepsy.
Miller W
Seizure. 2014; 23(8):592-7.
PMID: 24838071
PMC: 4440332.
DOI: 10.1016/j.seizure.2014.04.010.
Self-Management education for adults with poorly controlled epILEpsy (SMILE (UK)): a randomised controlled trial protocol.
Kralj-Hans I, Goldstein L, Noble A, Landau S, Magill N, McCrone P
BMC Neurol. 2014; 14:69.
PMID: 24694207
PMC: 3976555.
DOI: 10.1186/1471-2377-14-69.